Waters Corporation has announced a multi-year research collaboration with Princeton University, in the US, that will enable scientists, faculty, and students to work together to bring their diverse skills and backgrounds to solve complex challenges in biochemistry and materials science.
According to Dr Udit Batra, President and CEO, Waters Corporation, "Together our initial work will focus on improving LC-MS workflows and sample preparation to enable our customers to conduct simpler and faster analyses with even greater precision. In turn, this will help biopharma scientists deliver therapeutics that are safe and highly effective for the treatment of disease, such as oncology and autoimmune diseases."
"As a leading global institution of research and teaching, Princeton welcomes collaborations with industry to enrich education and accelerate research and innovation for societal benefit," said Craig Arnold, Princeton University Vice Dean for Innovation and the Susan Dod Brown Professor of Mechanical and Aerospace Engineering.
Under the new agreement, the Waters-Princeton collaboration will bring together academic and industry researchers to tap into knowledge and expertise from various scientific domains and disciplines to identify and solve problems that matter. One such research project will focus on novel media for purification to help advance drug development and discovery.